These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19996936)

  • 1. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
    Lidström J; Li Q; Hoover DR; Kafulafula G; Mofenson LM; Fowler MG; Thigpen MC; Kumwenda N; Taha TE; Eshleman SH
    AIDS; 2010 Jan; 24(3):381-6. PubMed ID: 19996936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
    Fogel J; Hoover DR; Sun J; Mofenson LM; Fowler MG; Taylor AW; Kumwenda N; Taha TE; Eshleman SH
    AIDS; 2011 Apr; 25(7):911-7. PubMed ID: 21487249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postexposure prophylaxis of breastfeeding HIV-exposed infants with antiretroviral drugs to age 14 weeks: updated efficacy results of the PEPI-Malawi trial.
    Taha TE; Li Q; Hoover DR; Mipando L; Nkanaunena K; Thigpen MC; Taylor A; Kumwenda J; Fowler MG; Mofenson LM; Kumwenda NI
    J Acquir Immune Defic Syndr; 2011 Aug; 57(4):319-25. PubMed ID: 21423025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
    Eshleman SH; Hoover DR; Hudelson SE; Chen S; Fiscus SA; Piwowar-Manning E; Jackson JB; Kumwenda NI; Taha TE
    J Infect Dis; 2006 Feb; 193(4):479-81. PubMed ID: 16425125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
    Church JD; Omer SB; Guay LA; Huang W; Lidstrom J; Musoke P; Mmiro F; Jackson JB; Eshleman SH
    J Infect Dis; 2008 Oct; 198(7):1075-82. PubMed ID: 18684096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
    Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
    Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
    AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.
    Lallemant M; Le Coeur S; Sirirungsi W; Cressey TR; Ngo-Giang-Huong N; Traisathit P; Klinbuayaem V; Sabsanong P; Kanjanavikai P; Jourdain G; Mcintosh K; Koetsawang S;
    AIDS; 2015 Nov; 29(18):2497-507. PubMed ID: 26372485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.
    Moorthy A; Gupta A; Bhosale R; Tripathy S; Sastry J; Kulkarni S; Thakar M; Bharadwaj R; Kagal A; Bhore AV; Patil S; Kulkarni V; Venkataramani V; Balasubramaniam U; Suryavanshi N; Ziemniak C; Gupte N; Bollinger R; Persaud D
    PLoS One; 2009; 4(1):e4096. PubMed ID: 19119321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
    Van Dyke RB; Ngo-Giang-Huong N; Shapiro DE; Frenkel L; Britto P; Roongpisuthipong A; Beck IA; Yuthavisuthi P; Prommas S; Puthanakit T; Achalapong J; Chotivanich N; Rasri W; Cressey TR; Maupin R; Mirochnick M; Jourdain G;
    Clin Infect Dis; 2012 Jan; 54(2):285-93. PubMed ID: 22144539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine.
    Micek MA; Blanco AJ; Carlsson J; Beck IA; Dross S; Matunha L; Seidel K; Montoya P; Gantt S; Matediana E; Jamisse L; Gloyd S; Frenkel LM
    J Infect Dis; 2012 Jun; 205(12):1811-5. PubMed ID: 22492850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Kumwenda NI; Hoover DR; Mofenson LM; Thigpen MC; Kafulafula G; Li Q; Mipando L; Nkanaunena K; Mebrahtu T; Bulterys M; Fowler MG; Taha TE
    N Engl J Med; 2008 Jul; 359(2):119-29. PubMed ID: 18525035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.
    McIntyre JA; Hopley M; Moodley D; Eklund M; Gray GE; Hall DB; Robinson P; Mayers D; Martinson NA
    PLoS Med; 2009 Oct; 6(10):e1000172. PubMed ID: 19859531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants.
    Anugulruengkitt S; Suntarattiwong P; Ounchanum P; Srirompotong U; Jantarabenjakul W; Sophonphan J; Punnahitanon S; Pancharoen C; Cressey TR; Chokephaibulkit K; Puthanakit T;
    Pediatr Infect Dis J; 2019 Oct; 38(10):1045-1050. PubMed ID: 31365477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers.
    Gray GE; Urban M; Chersich MF; Bolton C; van Niekerk R; Violari A; Stevens W; McIntyre JA;
    AIDS; 2005 Aug; 19(12):1289-97. PubMed ID: 16052084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.